Arenicin-1 vs Dulaglutide
Head-to-head comparison of Arenicin-1 (Arenicin-1) and Dulaglutide (Recombinant GLP-1 receptor agonist Fc fusion protein) — benefits, dosing, side effects, research data, and where to buy.
Research Score
| Property | Arenicin-1 | Dulaglutide |
|---|---|---|
| Category | Marine-Derived | Weight Management |
| Full Name | Arenicin-1 | Recombinant GLP-1 receptor agonist Fc fusion protein |
| Molecular Weight | 2079 Da | ~63,000 Da |
| Half-Life | n/a | About 5 days |
| Amino Acids | 21 | N/A |
| Typical Dose | n/a | 0.75-4.5 mg weekly |
| Route | preclinical | Subcutaneous |
| Purity | ≥98% | ≥98% |
| Studies Count | 76 | 700 |
| Research Status | Pre-clinical | Approved |
Arenicin-1 Benefits
- ✓antimicrobial
- ✓anti-biofilm
- ✓membrane-active
Dulaglutide Benefits
- ✓modest weight loss
- ✓lower A1c
- ✓weekly dosing convenience
- ✓cardiometabolic benefit
Arenicin-1 Dosing
bacterial infection|biofilm disruption
Dulaglutide Dosing
0.75-4.5 mg SC weekly|Increase based on response and tolerance|Administer on the same day each week
Arenicin-1 Side Effects
- ⚠Arenicola marina
Dulaglutide Side Effects
- ⚠nausea
- ⚠diarrhea
- ⚠injection-site reactions
Research Overview
Arenicin-1
Marine annelid peptide with strong preclinical antibacterial activity and a stable structural motif that is useful for peptide engineering.
Dulaglutide
Dulaglutide has repeatedly shown small-to-moderate reductions in body weight alongside glycemic improvement in large diabetes trials. It is a useful comparator for GLP-1 receptor agonist effects on appetite and weight.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.